Characterization of a GSK-3 inhibitor in culture of human cord blood primitive hematopoietic cells
Junfen Jiang a 1, Mei Zhao a b 1, Aiying Zhang c 1, Mingfeng Yu c, Xiaojuan Lin a, Mingyuan Wu a, Xiaonong Wang d, Huili Lu a, Shunying Zhu a, Yan Yu e, Zhenmin Mao c
, Wei Han a

| pages | 5 |
| Iconographies | 2 |
| Vidéos | 0 |
| Autres | 0 |
Abstract
Wnt signaling pathway plays important roles in the biology of stem cells in maintaining their self-renewal property. Glycogen synthase kinase-3 (GSK-3) inhibitors, the Wnt signaling agonists, maintain the pluripotency of embryonic stem cells. We report here that a synthetic GSK-3 inhibitor, 6-bromoindirubin-3′-oxime (BIO), showed opposite effects on the expansion of human primitive hematopoietic cells isolated from umbilical cord blood (UCB). In combination with human c-kit ligand (KL), BIO at low concentration (0.2μM) enhanced the expansion of UCB CD34+ cells, which was BIO structure and exposure time dependent; however, at high concentration (2μM) it inhibited the expansion of the cells. Furthermore, hematopoietic stem cells (HSCs) were exhausted when the UCB CD34+ cells were exposed to 0.2μM BIO and KL longer than 2 days. In conclusion, the use of BIO in expansion of UCB HSCs remains a significant challenge.
Keywords : Human umbilical cord blood, CD34+ cells, GSK-3 inhibitor, BIO
Plan
Vol 64 - N° 7
P. 482-486 - septembre 2010 Retour au numéroBienvenue sur EM-consulte,
la référence des professionnels de santé.
Plus de 500 000 articles médicaux,
paramédicaux et scientifiques vous attendent.
L'accès au texte intégral de cet article nécessite un abonnement ou un achat à l'unité.
Déjà abonné à cette revue ?

